Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Maximizing Treatment Outcome in OCD.

Trial Profile

Maximizing Treatment Outcome in OCD.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Risperidone (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2015 Results assessing exposure and response prevention published in the Journal of Clinical Psychiatry (n = 32).
    • 11 Sep 2013 Primary endpoint 'Yale-Brown-Obsessive-Compulsive-Scale' has been met for cognitive behavioural therapy but not for risperidone according to results published in JAMA Psychiatry.
    • 11 Sep 2013 Results published in JAMA Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top